Cite
HARVARD Citation
Ferrante, M. et al. (n.d.). OP25 Patients with moderate to severe Crohn's Disease with and without prior biologic failure demonstrate improved endoscopic outcomes with risankizumab: Results from phase 3 induction and maintenance trials. Journal of Crohn's and colitis. pp. i027-i028. [Online].